Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion

The US Food and Drug Administration (FDA) has said it will not review Moderna’s application for its experimental influenz...

Impressions : 1261

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

In this week’s Phispers, we bring you the split story of two GLP-1 drugmakers — Eli Lilly and Novo Nordisk. While L...

Impressions : 862

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 1363

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 1203

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

Ajanta Pharma's Generics Methazolamide Receives Approval in US

Mankind Pharma's Generics Ticagrelor Receives Approval in US

Steranco's Generics Nystatin Receives Approval in US

Gland's Generics Zoledronic Acid Receives Approval in US

Apotex's Generics Hydrocortisone Succinate Receive Approval in US

Alembic's Generics Carbidopa, Levodopa Receives Approval in US

MSN's Generics Bumetanide Receives Approval in US

Hikma's Generics Aztreonam Receives Approval in US

Aurobindo's Generics Solriamfetol Receives Tent. Approval in US

Eugia' Generics Nintedanib Receives Tentative Approval in US

Conceive Fertility Center's Receives FDA Warning Letter

Boothwyn Pharmacy's Receives FDA Warning Letter

Signature Formulations' Receives FDA Warning Letter

Bio Medical Manufacturing's Receives FDA Warning Letter

Mark S Dacey's Receives FDA Warning Letter

Central Coast Multispecialty's Receives FDA Warning Letter

ProDx Health's Receives FDA Warning Letter

Enforcement Report - Week of February 4, 2026

Cohance Lifesciences' Receives FDA Warning Letter

HTO Nevada's Receives FDA Warning Letter

CStone Advances Trispecific Antibody CS2009 To Phase II Trial

Medical groups urge US judge to block vaccine policy shifts

Sapu Bioscience Expands International IP Coverage for OT-101

Zydus Gets USFDA Nod For Ammonium Lactate Cream 12%

NATCO Receives CDSCO Approval For Semaglutide In India

CPRIT's $6B Cancer Program Awaits Public Evaluation

Adven Biotech: India's First NABL-Accredited Homeopathy Brand

Torrent Pharma Q3 Profit at Rs 577 Cr, 9-Month Rs 1,725 Cr

GST Rejig Signals Shift to Affordable Cancer Care at AIIMS

Ayush Export Declines By 7.4% In First Nine Months Of FY 26

Zydus Gets USFDA Nod For Ammonium Lactate Cream 12%

NATCO Receives CDSCO Approval For Semaglutide In India

Akums Receives First UK MHRA Approval For Rivaroxaban

Difgen Pharma Secures FDA Approval for Fluorometholone Eye Drops

SFDA Approves OneSource's Generic Semaglutide in Saudi Arabia

GSK, Teva Quietly Settle Coreg 's Label' Dispute

Warburg-Mubadala Team Up, Emerge As Frontrunner For Encube

Hims Quits On Obesity Pill After Legal, Regulatory Heat

SQ Innovation Launches Lasix® ONYU With U.S. Pharma Distributors

Pharma Companies Advocate For Policy Clarity To Safeguard

CStone Advances Trispecific Antibody CS2009 To Phase II Trial

Medical groups urge US judge to block vaccine policy shifts

Sapu Bioscience Expands International IP Coverage for OT-101

Bioasia 2026 Positions Telangana As A Global Techbio Powerhouse

STADA and Bio-Thera Secure EU Approval for Gotenfia

BREZTRI Shows Positive Phase III Results In Uncontrolled Asthma

Novartis Vanrafia Shows Phase III Data Backing Kidney Function

Soin and Lilac Bio Launch Collaboration to Study RNA Signatures

Advanced Bio Announces Feasibility Study With Chi-Mei Center

Indian Sceintists Intensify Research to Develop Rabies Vaccine

Procurement Lessons From India's Pharma Sector

Fresenius, Phlow Link Up To Boost US Epinephrine Injection Supply

Lalitpur Bulk Drugs Park In UP Commences Phase-I With Approved

Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit

Bdmai Launches E-Marketing Portal For Indian Pharma Expansion

Fis Successfully Completes €770 Million Bond Issuance

Wanbury Reaches First Sales Invoicing Shipment Milestone

Piramal Pharma Solutions Launches Tablet-In-Capsule Services

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

FDA Launches Program to Boost Domestic Drug Manufacturing

Haryana FDA Raids Target Drugs in Hisar, Karnal, and Kalanwali

FDA Issues Form 483 with 4 Observations to Piramal

FDA Cites Firms For CGMP And Testing Violations

Philly Jury Awards $250K vs. J&J in Baby Powder Trial

NIH Stops Xarelto Arm Of Stroke Trial Due To Safety, Efficacy

FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad

Haryana FDA Cracks Down on Banned Vet Drugs to Protect Livestock

FDA Untitled Letters Target Drug Ads From Novo, Argenx, Sobi

US FDA Inspects Anuh Pharma's Tarapur Facility

Piramal's Plant: Supreme Court to Gujarat Pollution Control Board

CPRIT's $6B Cancer Program Awaits Public Evaluation

GST Rejig Signals Shift to Affordable Cancer Care at AIIMS

Conavi Medical Showcases Benefits Of Hybrid IVUS-OCT Imaging